Multiparametric MRI can detect pathologic complete response after neoadjuvant therapy in patients with esophageal squamous cell carcinoma.
In patients with esophageal squamous cell carcinoma (SCC), multiparametric magnetic resonance (MR) features provide useful diagnostic information of pathologic complete response after neoadjuvant therapy. This is according to a study presented at the Radiological Society of North America (RSNA) 2021 Annual Meeting.
“Multiparametic MR features provide useful diagnostic information of pathologic complete response among patients with esophageal SCC who undergo neoadjuvant therapy,” the authors wrote.
Please visit Diagnostic Imaging to read full article
